ICOVIR-5, that employs a deregulated E2F-Rb (retinoblastoma) pathway which is very common in tumor cells,49 is evaluated in a single-shot intravenous dose-escalation study in melanoma patients (NCT01864759; Figure 6b). The gene discussed is RB1; the disease is melanoma.